New painkiller may offer safer relief after eye surgery

NCT ID NCT07269106

First seen Dec 18, 2025 · Last updated May 11, 2026 · Updated 26 times

Summary

This study tests if a drug called Anrikefon can control pain after eye surgery as well as a standard painkiller, but with fewer side effects like drowsiness. About 204 adults having eye surgery under general anesthesia will receive either Anrikefon or the standard drug during their procedure. Researchers will measure pain levels, side effects, and how quickly patients recover and go home.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eye & ENT Hospital of Fudan University

    NOT_YET_RECRUITING

    Shanghai, 200031, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Affiliated Hospital of Yunnan University

    NOT_YET_RECRUITING

    Kunming, Yunnan, 650000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Zhongshan Ophthalmic Center, Sun Yat-Sen University

    RECRUITING

    Guangzhou, Guangdong, 510060, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.